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Abstract
Alcohol dependence (AD) is a complex disorder characterized by psychiatric and physiological dependence on alcohol. AD
is reflected by regular alcohol drinking, which is highly inheritable. In this study, to identify susceptibility genes associated
with alcohol drinking, we performed a genome-wide association study of copy number variants (CNVs) in 2,286 Caucasian
subjects with Affymetrix SNP6.0 genotyping array. We replicated our findings in 1,627 Chinese subjects with the same
genotyping array. We identified two CNVs, CNV207 (combined p-value 1.91E-03) and CNV1836 (combined p-value 3.05E-03)
that were associated with alcohol drinking. CNV207 and CNV1836 are located at the downstream of genes LTBP1 (870 kb)
and FGD4 (400 kb), respectively. LTBP1, by interacting TGFB1, may down-regulate enzymes directly participating in alcohol
metabolism. FGD4 plays a role in clustering and trafficking GABAA receptor and subsequently influence alcohol drinking
through activating CDC42. Our results provide suggestive evidence that the newly identified CNV regions and relevant
genes may contribute to the genetic mechanism of alcohol dependence.
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Introduction
Alcohol is the most widely used addictive substance, affecting
billions of people worldwide. Alcohol dependence (AD) is
characterized by psychiatric and physiological dependence
(withdrawal and tolerance) as well as behavioral indices of
addiction on alcohol [1]. It is a common complex disease
determined by both genetic and environmental factors; the
estimated heritability through family and twin and adoption
studies [2,3,4] is as high as 40 to 60%. Therefore, the identification
of genes that contribute to AD variation will improve our
understanding of genetic mechanism that underlies this disorder.
Regular drinking is necessary for the development of AD. The
heaviness of alcohol consumption including the frequency and
amount of alcohol drinking is strongly associated with AD risk.
Alcohol consumption is largely determined by genetic factors.
Most recently, at least two genome-wide association studies
(GWASs) have identified TMEM108, ANKS1A and AUTS2 as
possible risk genes for alcohol consumption in European-origin
populations [5,6]. Recent studies have also demonstrated that
there is a high degree of genetic overlap between AD and
heaviness of consumption even among non-dependent individuals
in the general population [7]. Genes affecting alcohol intake also
affect AD risk [8]. Therefore, genetic study on alcohol drinking
will likely have a useful role in the identification of genes
contributing to AD.
Genome-wide linkage study (GWLS) have identified a number
of loci potentially linked to AD [9,10,11,12]. Association studies
have also implicated several associated genes, such as ALDH2,
GABRA2, DRD2 [13,14,15]. However, the identified genes could
only account for a small proportion of genetic variation, leaving
the vast majority of heritability unknown. The limitation of
traditional association studies is that they focus on single
nucleotide polymorphisms (SNPs) only, while the human genome
exhibits various types of genomic variation. The ‘‘missing’’
heritability may be hidden in these extensive types of variants.
Recent studies have shown that another type of genomic
variation, copy number variations (CNVs), plays a significant role
in influencing common diseases as well [16,17]. CNV is a DNA
segment that is one kilo bases or larger and presents at variable
copy numbers in comparison with reference genome [18]. It
covers approximately 12% (,360 Mb) of the human genome [19].
CNVs may influence gene expression, phenotypic variation and
adaptation by disrupting genes and altering gene dosage, and can
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gene expression indirectly through position effects, predispose to
deleterious genetic changes, or provide substrates for chromosome
change in evolution [18,24,25,26]. Many diseases are found to be
associated with copy number changes, including schizophrenia
[27,28], Parkinson’s disease [29], autism [30] and HIV/AIDS
susceptibility [31]. Therefore, investigation of CNVs would
contribute to unravel the genetic basis of complex diseases and
phenotypes.
In this study, to uncover the genetic basis of alcohol drinking
caused by CNVs, we conducted a genome-wide association study
in 2,286 Caucasian subjects with Affymetrix SNP6.0 genotyping
array. We further replicated our findings in 1,627 Chinese
subjects.
Materials and Methods
Ethics Statement
The study was approved by Institutional Review Boards of
Creighton University, University of Missouri-Kansas City, Hunan
Normal University of China and Xi’an Jiaotong University of
China. Signed informed-consent documents were obtained from
all study participants before they entered the study.
Subjects
1) Discovery sample. The discovery sample consisted of
2,286 unrelated Caucasian subjects that were recruited in
Midwestern US in Kansas City, Missouri and Omaha, Nebraska.
All identified subjects were of European origin. Subjects with certain
conditions were excluded, including chronic disorders involving vital
organs (heart, lung, liver, kidney, brain), serious metabolic diseases
(diabetes, hypo- and hyper-parathyroidism, hyperthyroidism, etc.),
skeletal diseases (Paget disease, osteogenesis imperfecta, rheumatoid
arthritis, etc.), chronic use of drugs affecting bone metabolism
(hormone replacement therapy, corticosteroid therapy, anti-
convulsant drugs), and malnutrition conditions (such as chronic
diarrhea, chronic ulcerative colitis, etc.).
2) Replication sample. To replicate the associations for
CNVs at significant level of p,0.05, we performed another
independent study in 1,627 unrelated subjects of Chinese Han
population. All subjects were recruited from the cities of Xi’an/
Changsha and their neighboring areas in China.
Phenotyping
In Diagnostic Interview for Genetic Studies (DIGS) [32], they
defined ‘‘Regular Drinking’’ as drinking at least once a week. With
6,006 Caucasian subjects from 1,131 pedigrees, we confirmed that
this kind of ‘‘Regular Drinking’’ was genetically determined and
the heritability estimation was ,40% (unpublished data). So we
adopted ‘‘Regular Drinking’’ as phenotype and considered
subjects with drinking at least once per week as cases and subjects
with drinking less than once per week as controls. For alcohol
drinkers, alcohol consumption information was also collected.
Alcohol consumption is graded as 1, 2, 3 and 4, representing
drinking alcohol 1–2, 3–6, 7–10 and .10 times per week,
respectively.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes
using standard protocols. Genotyping with Affymetrix Genome-
Wide Human SNP Array 6.0, which features 1.8 million genetic
markers, including more than 906,600 SNPs and more than
946,000 probes for detection of copy number variation, was
performed using the standard protocol recommended by the
manufacturer. Fluorescence intensities were quantified using an
Affymetrix array scanner 30007 G. Data management and
analyses were performed using the AffymetrixH GeneChipH
Command ConsoleH Software (AGCC). Contrast quality control
(QC) threshold was set at the default value of greater than 0.4 for
sample quality control. The final average contrast QC across the
entire sample reached the high level of 2.32. The Birdsuite
package [33] was used for genotype calling, genotyping quality
control, and CNV identification.
For the discovery sample, common CNVs were identified using
the CANARY algorithm implemented in the Birdsuite software
[33], which utilized a previously defined copy number variation
map based on HapMap samples. In total, 1,316 CNVs were
genotyped for all the subjects in the discovery sample.
In order to generate results with high confidence, we conducted
quality control (QC) filtering both at the sample level and the
CNV level. First, for the sample level QC, we used three quality
metrics reported by the Birdsuite method to evaluate the initial
2,286 subjects for quality in copy number genotyping. The
following procedures were adopted: 1) we removed any sample
that was greater or less than three standard deviations (SD) from
the average estimate of copy number, which was approximate two
copies at genome-wide level; 2) we calculated the variability in
copy number and SNP probe intensities with each standardized
per chromosome. We removed any sample with more than three
SDs than these estimates on the average genome-wide level; 3) we
removed any sample in which more than two chromosomes failed
any of these three metrics, i.e. more than three SD in estimated
copy number or excessive CNV or SNP variability for chromo-
some. According to above criteria, 71 subjects were discarded, the
copy number of the remaining 2,215 subjects including 938 cases
and 1,277 controls were successfully genotyped by the CANARY
software.
Second, we conducted QC filtering at the CNV level. Out of the
initial 1,316 CNVs, we discarded the CNVs with confidence score
greater than 10% or with less than 1% of allele frequency (AF) that
refers to the total proportion of the subjects with copy number less
or more than two in total sample. Of the initial full-set of 1,316
CNVs, there are 501 CNVs with AF,1%, 268 CNVs with
confidence score greater than 0.10 and 4 CNVs with both. As a
result, 551 CNVs were available for subsequent association
analyses.
Statistical analyses
Statistical analyses of CNV-based association were performed
by a logistic regression model in R package glm [34]. The copy
number was used as a predictor of alcohol drinking. Age and sex
were included as covariates in the model. To correct for the effect
of potential population stratification, we performed a principal
component analysis on genome-wide SNP data with EIGEN-
STRAT [35] and included the top ten principal components as
covariates. After correcting for the effects of all covariates, we also
exponentiated the coefficients for the CNVs and interpreted them
as odds ratios (ORs). Fisher’s method [36] was used to combine
the p-values from both the discovery and replication samples.
We further tested the association of alcohol drinking and SNPs
that locate in CNV regions. The association was tested by a logistic
regression model.
Results
The basic characteristics of the subjects used in both discovery
and replication samples, including sex, age, number of subjects
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summarized in Table 1.
In the discovery sample, 30 CNVs were associated with regular
alcohol drinking at the significance level 0.05 (Table S1). Two of
them, CNV207 and CNV1836, were further replicated in the
replication sample. The p-values of CNV207 in the discovery and
replication samples were 2.27E-02 and 8.87E-03; and those of
CNV1836 were 8.13E-03 and 4.17E-02, respectively (Table 2).
The odds ratios (ORs) of CNV207 in the discovery and replication
samples were 1.16 (95% CI: 1.02–1.32) and 0.40 (95% CI: 0.21–
0.82), respectively and those of CNV1836 in the discovery and
replication samples were 1.22 (95% CI: 1.05–1.42) and 1.62 (95%
CI: 1.02–2.72), respectively. The combined p-values of these two
CNVs were 1.91E-03 and 3.05E-03, respectively. Though neither
of the combined p-values achieved Bonferroni corrected signifi-
cance level (9.07E-5), they offered suggestive signals of potential
associations.
CNV207 is located in the chromosome region 2p22 with
physical position ranging from 34,552,819 bp to 34,590,561 bp. It
is in the 870 kb downstream of the gene transforming growth
factor beta-1 binding protein 1(LTBP1). The numbers of carriers
with 0, 1 and 2 copies were 287, 1087 and 810 in the discovery
sample and 0, 71 and 1220 in the replication sample, respectively.
Individuals with more CNs trended to have higher percentage of
alcohol drinkers in the discovery sample, but individuals with more
CNs trended to have lower percentage of alcohol drinkers in the
replication sample (Figure 1).
CNV1836 is located in the chromosome region 12p11 with
physical position ranging from 33,192,673 bp to 33,198,641 bp.
It is in the 400 kb downstream of the gene actin-filament
binding protein frabin (FGD4). The number of carriers of 0, 1
and 2 copy numbers was 102, 729 and 1353 in the discovery
sample and 17, 264 and 1011 in the replication sample,
respectively. Subjects with 1 copy number had the lowest
percentage of alcohol drinkers in both discovery and replication
samples (Figure 1).
There are two SNPs that are located in the region of CNV207
(rs7593687 and rs7583665) and four in the region of CNV1836
(rs10772040, rs983985, rs7972327 and rs2018498). None of these
six SNPs was significantly associated with alcohol drinking in both
samples (Table 3).
Discussion
In this study, we have performed a CNV-based genome-wide
association study of alcohol drinking in 2,286 Caucasian subjects,
and replicated in 1,627 Chinese subjects. We identified CNV207
and CNV1836 to be suggestively associated with alcohol drinking
in both discovery and replication samples. Although the
Bonferroni corrected p-values for CNV207 and CNV1836 are
not significant, they were replicated in distinct populations and
might be more generalizable to other populations, and would be
more likely to be causal in nature [37].
LTBP1 plays a critical role in controlling and directing the
activity of transforming growth factor beta 1 (TGFB1) [38], which
encodes a member of the transforming growth factor beta (TGFB)
family. TGFB modulates the expression of genes involved in a
variety of biological process, including alcohol metabolism and
oxidative stress. In previous studies, Saltzman et al. [39] reported
that alcohol drinking was associated with serum TGFB1 levels.
Ciuclan et al. [40] found that enzymes directly participating in
alcohol metabolism were down-regulated by TGFB. TGFB was
also found to strongly promote alcohol dependent oxidative stress
and anti-oxidant depression leading to enhanced cellular toxicity
[40]. This ‘‘alcohol damage promoting’’ effect of TGFB was
further supported by the finding that ethanol induced lipid
peroxidation was increased upon parallel activation of its signaling
pathway [40]. Therefore LTBP1 may influence alcohol drinking
through its regulation effect on TGFB family.
Another relevant gene is FGD4. It activates the gene CDC42,
which has a specific role in clustering and trafficking of GABAA
receptors [41,42]. There is a large body of evidence showing that
Table 1. Basic characteristics of the study subjects.
Discovery Sample Replication Sample
Total Male Female Total Male Female
No. of subjects 2286 558 1728 1627 802 825
Age 51.37(13.75) 50.71(16.05) 51.58(12.92) 34.49(13.24) 31.43(7.97) 37.46(13.77)
No. of alcohol drinkers 972 296 676 167 137 30
Drinking consumption 2.14(1.00) 2.51(1.15) 1.98(0.88) - - -
Note: age and drinking consumption are presented as mean (standard deviation).
doi:10.1371/journal.pone.0030860.t001
Table 2. Characteristics of the interesting CNVs for association analysis.
Name Chr Start End Discovery Sample Replication Sample
Combined
P-value
P-value AF CS
a OR(95% CI) P-value AF CS
a OR(95% CI)
CNV1836 12 33,192,673 33,198,641 8.13E-03 0.38 0.005 1.22(1.05–1.42) 4.17E-02 0.24 0.028 1.62(1.02–2.72) 3.05E-03
CNV207 2 34,552,819 34,590,561 2.27E-02 0.63 0.003 1.16(1.02–1.32) 8.87E-03 0.07 0.011 0.40(0.21–0.82) 1.91E-03
a. CS denotes confidence score.
doi:10.1371/journal.pone.0030860.t002
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effects of ethanol in the central nervous system [43]. Therefore,
FGD4 gene may play a role in clustering and trafficking GABAA
receptor through activating CDC42 and subsequently influence
alcohol drinking.
It is not surprising that the two related genes are not located in
the respective CNV regions. A previous genome-wide association
study between CNVs and gene expression levels showed that more
than half of the associated genes were not located in any CNV
interval [44]. These observations suggest that rather than altering
gene dosage, CNV could also affect regulatory regions and other
functional regions that have an impact on gene expression [44].
Stranger et al. [45,46] showed that genes could be implied from
CNVs as long as 2 MB apart, as confirmed by extensive studies in
animal models [47,48].
Notice that for CNV207, the association directions in the
discovery and replication studies were not consistent. This
inconsistency may be explained by the following reasons: first,
genetic variants could have differences, such as different allele
frequencies among diverse populations because of different
evolution histories, resulting in different modes of genotype-
phenotype association [49]. According to a recent study,
replicable findings in distinct populations might be more
generalizable to other populations, and would be more likely
to be causal in nature [37]. Second, in the context of GWAS,
significant associations are usually declared at genetic markers
that are in linkage disequilibrium with causal site, rather than the
causal site itself. Therefore, the directional inconsistency could
be a result of opposite patterns of LD between the two
populations.
Figure 1. Percentage of alcohol drinkers in groups with different copy number (CN) of CNV207 and CNV1836 in the discovery and
replication samples.
doi:10.1371/journal.pone.0030860.g001
Table 3. Association between SNPs located in CNV207 and CNV1836 region and alcohol drinking.
CNV region CHR SNP Discovery sample Replication sample
Allele
a MAF P-value
b Allele
a MAF P-value
b
CNV207 2 rs7593687 A/G ,0.01 NA A/G ,0.01 NA
2 rs7583665 T/C 0.02 0.75 T/C ,0.01 NA
CNV1836 12 rs10772040 A/C 0.09 0.88 C/A 0.22 0.08
12 rs983985 C/T 0.37 0.19 T/C 0.04 0.16
12 rs7972327 C/G 0.09 0.99 G/C 0.12 0.97
12 rs2018498 A/G 0.37 0.19 G/A 0.04 0.16
a. The second allele is the minor allele in the sample;
b. NA: not available due to the low minor allele frequency.
doi:10.1371/journal.pone.0030860.t003
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regions, implying that CNV may take the effect alone.
In summary, we have indentified two CNVs, CNV207 and
CNV1836, that were suggestively associated with alcohol drinking.
The two relevant genes, LTBP1 and FGD4, may play important
roles in the metabolism of alcohol dependence. Our findings may
provide informative candidate genes for further functional studies
of alcohol dependent traits.
Supporting Information
Table S1 Information of 30 CNVs with p,0.05 in discovery
sample.
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